Robert Theodore Adds to Technology and Healthcare Sectors Amidst Fed’s Unlimited QE

Entering the second quarter of 2020, the Federal Reserve not only maintained ultra-low interest rates, but also announced unlimited quantitative easing with direct purchases of Treasuries, mortgage-backed securities, and some corporate debt, resulting in an unprecedented abundance of market liquidity. Against this background, the speed of repair of U.S. stocks exceeded most people’s expectations, and funds continued to flow into high-growth, high-confidence industries. Robert Theodore clearly focused his main investment line on the technology and healthcare sectors at this time, capitalizing on the window of policy dividends resonating with structural demand to further amplify the growth potential of the portfolio.

In the technology sector, he prioritized positions in cloud computing, semiconductors, high-performance computing chips, and e-commerce infrastructure companies. These companies have not only sustained their earnings growth during the epidemic, but also gained longer-term growth logic due to the accelerating global digital transformation. Robert believes that in an environment of ultra-low interest rates and flooding liquidity, capital will be willing to pay a premium for high growth, which is the golden phase for tech leaders.

The healthcare sector is his other major allocation direction during this period. The epidemic has accelerated the digital upgrade of the global healthcare system and the popularization of telemedicine, and companies in vaccine research and development, medical testing and protective equipment production have become the focus of the market. When selecting targets, he prioritized companies with leading advantages in R&D pipeline, patent reserves and international market expansion to ensure investment sustainability and margin of safety.

In terms of execution strategy, he adopts a two-tier structure of “core positions + tactical trading”. Core positions focus on industry leaders with high certainty and are held for the medium to long term. Tactical trading capitalizes on short-term fluctuations and thematic catalysts (e.g., policy announcements, industry conferences, quarterly earnings reports) to adjust positions and arbitrage, in order to enhance the overall flexibility and return elasticity of the portfolio.

As of June, the linked rally in the technology and healthcare sectors has generated significant excess returns for his portfolio. Robert points out that in an unlimited QE environment, the traditional valuation ceiling is further elevated and the market will place more emphasis on a company’s growth path and competitive barriers. As a result, he will remain deeply positioned around these two sectors in the coming months, while maintaining a certain percentage of cash and liquidity instruments for possible market pullbacks.